Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
7.46
+0.08 (1.08%)
At close: Dec 23, 2024, 4:00 PM
7.49
+0.03 (0.40%)
After-hours: Dec 23, 2024, 6:57 PM EST
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $2.27 billion as of December 23, 2024. Its market cap has increased by 32.01% in one year.
Market Cap
2.27B
Enterprise Value
1.96B
1-Year Change
32.01%
Ranking
Category
Stock Price
$7.46
Market Cap Chart
Since October 15, 2010, Iovance Biotherapeutics's market cap has increased from $79.00M to $2.27B, an increase of 2,778.06%. That is a compound annual growth rate of 26.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.25B | 8.11% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 69.79% |
| Dec 31, 2014 | 217.50M | 9.63% |
| Dec 31, 2013 | 198.40M | 1,053.49% |
| Dec 31, 2012 | 17.20M | -78.23% |
| Dec 30, 2011 | 79.00M | 5.05% |
| Dec 31, 2010 | 75.20M | -4.81% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewAmsterdam Pharma Company | 2.36B |
| Beam Therapeutics | 2.31B |
| Azenta | 2.30B |
| Ardent Health Partners | 2.29B |
| Centessa Pharmaceuticals | 2.26B |
| IDEAYA Biosciences | 2.21B |
| Ligand Pharmaceuticals | 2.17B |
| GeneDx Holdings | 2.13B |